- Home
- KLIC vs TARS Comparison
KLIC vs TARS Comparison
Compare KLIC & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLIC
- TARS
- Stock Information
- Founded
- KLIC 1951
- TARS 2016
- Country
- KLIC United States
- TARS United States
- Employees
- KLIC N/A
- TARS N/A
- Industry
- KLIC Semiconductors
- TARS Medicinal Chemicals and Botanical Products
- Sector
- KLIC Technology
- TARS Health Care
- Exchange
- KLIC Nasdaq
- TARS Nasdaq
- Market Cap
- KLIC 2.4B
- TARS 1.8B
- IPO Year
- KLIC N/A
- TARS 2020
- Fundamental
- Price
- KLIC $35.59
- TARS $46.47
- Analyst Decision
- KLIC Strong Buy
- TARS Strong Buy
- Analyst Count
- KLIC 5
- TARS 6
- Target Price
- KLIC $52.00
- TARS $63.67
- AVG Volume (30 Days)
- KLIC 627.5K
- TARS 660.3K
- Earning Date
- KLIC 04-30-2025
- TARS 02-25-2025
- Dividend Yield
- KLIC 2.31%
- TARS N/A
- EPS Growth
- KLIC N/A
- TARS N/A
- EPS
- KLIC 0.06
- TARS N/A
- Revenue
- KLIC $701,167,000.00
- TARS $182,953,000.00
- Revenue This Year
- KLIC $7.12
- TARS $90.93
- Revenue Next Year
- KLIC $19.40
- TARS $46.04
- P/E Ratio
- KLIC $583.14
- TARS N/A
- Revenue Growth
- KLIC N/A
- TARS 948.62
- 52 Week Low
- KLIC $35.04
- TARS $20.08
- 52 Week High
- KLIC $53.71
- TARS $57.28
- Technical
- Relative Strength Index (RSI)
- KLIC 30.97
- TARS 48.09
- Support Level
- KLIC $35.04
- TARS $43.16
- Resistance Level
- KLIC $38.18
- TARS $49.90
- Average True Range (ATR)
- KLIC 1.44
- TARS 2.99
- MACD
- KLIC -0.15
- TARS 0.40
- Stochastic Oscillator
- KLIC 8.03
- TARS 63.86
About KLIC Kulicke and Soffa Industries Inc.
Kulicke & Soffa Industries Inc is a United States-based company that is principally engaged in designing, manufacturing, and selling capital equipment and expendable tools that are used for assembling semiconductor devices. The company has four reportable segments which includes Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, and Aftermarket Products and Services. Its Ball Bonding Equipment segment which generates the majority of the revenue for the company includes results of the company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment. The majority of its customers are located in the Asia-pacific region.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.